Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 13/20 | 0.56 |
| ▸ | F11 | P03951 | 5/20 | 0.51 |
| ▸ | TPSB2 | P20231 | 4/20 | 0.51 |
| ▸ | PLAU | P00749 | 2/20 | 0.51 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.51 |
| ▸ | PLG | P00747 | 1/20 | 0.51 |
| ▸ | F7 | P08709 | 1/20 | 0.51 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29852662 | 1.00 | CFD (0.56) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218541 | 0.89 | CFD (0.66) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29852892 | 0.89 | CFD (0.66) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29852984 | 0.86 | CFD (0.56) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218082 | 0.86 | CFD (0.56) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL28736136 | 0.82 | CFD (0.73) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29592574 | 0.82 | CFD (0.73) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23219125 | 0.80 | TBXAS1 (0.45) | CFDMETSLC2A2TBXAS1 | |
| SCHEMBL29852848 | 0.80 | TBXAS1 (0.45) | CFDMETSLC2A2TBXAS1 | |
| SCHEMBL23218214 | 0.78 | CFD (0.59) | CFDF11TPSB2PLAUKLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021072198-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |
| WO-2021072198-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |